ASTH — Astrana Health, Inc. stock price, charts and financials

QT74Astrana Health, Inc.

Astrana Health, Inc. (NASDAQ: ASTH) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
37.47
+1.71+4.78%
ASTHQT74Astrana Health, Inc.·NASDAQ
37.47+4.78%
Earnings
Up 4.8% — Reported earnings — EPS in line, revenue beat by 2%.
High confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E43.21EPS (ttm)0.83Insider Own42.71%Shs Outstand49.58MPerf Week0.56%
Market Cap1.77BForward P/E19.62EPS next Y1.82Insider Trans0.00%Shs Float39.24MPerf Month-23.61%
Enterprise Value2.35BPEG0.76EPS next Q-Inst Own-Short Float6.83%Perf Quarter-0.89%
Income40.96MP/S0.46EPS this Y143.90%Inst Trans-Short Ratio4.56Perf Half Y64.72%
Sales3.84BP/B2.12EPS next Y43.74%ROA1.78%Short Interest2.68MPerf YTD44.14%
Book/sh-P/C9.98EPS next 5Y29.62%ROE5.09%52W High54.07 -30.70%Perf Year63.96%
Cash/sh-P/FCF11.19EPS past 3/5Y-22.55% -14.55%ROIC4.10%52W Low18.94 97.79%Perf 3Y-1.43%
Dividend Est.-EV/EBITDA13.45Sales past 3/5Y40.63% 53.78%Gross Margin9.22%Volatility4.49% 5.13%Perf 5Y-59.53%
Dividend TTM-EV/Sales0.61EPS Y/Y TTM-42.22%Oper. Margin2.61%ATR (14)2.04Perf 10Y550.18%
Dividend Ex-Date-Quick Ratio1.23Sales Y/Y TTM18.87%Profit Margin1.05%RSI (14)34.99Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.23EPS Q/Q114.29%SMA20-11.61%Beta0.87Target Price49.60
Payout4.82%Debt/Eq1.18Sales Q/Q55.65%SMA50-13.02%Rel Volume1.49Prev Close35.76
Employees3,000LT Debt/Eq1.83EarningsAug 06SMA20017.31%Avg Volume611.89KPrice37.47
IPO DateMar 11, 2009Option/ShortYes / YesEPS/Sales Surpr.0.42% 1.67%Net Debt/EBITDA3.31Volume909,356Change4.78%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-14-26ReiteratedBTIGBuy$40$65
May-26-26UpgradeBarclaysEqual WeightOverweight$37$50
May-14-26ReiteratedTruist SecuritiesBuy$47
May-11-26ReiteratedBarclaysEqual Weight$26$37
May-08-26ReiteratedRobert W. Baird$40$45
May-08-26ReiteratedNeedhamBuy$28$41
Apr-15-26ReiteratedRobert W. Baird$37$40
Feb-02-26ReiteratedBTIGBuy$70$40
Dec-12-25InitiatedNeedhamBuy$28
Nov-25-25ReiteratedJefferiesBuy$37
Latest News
Aug-07-26
Aug-06-26
Aug-05-26
Jul-31-26
Jul-16-26
Jul-14-26
Jul-13-26
Jul-03-26
Jul-02-26
Company

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,4193,1822,035
Cost of Goods Sold Incl. D&A2,1332,8861,763
Gross Profit285296271
Selling, General and Administrative Excl. Other175217154
Research and Development
000
Other Operating Expense41028
Operating Income707989
Interest Expense315033
Unusual Expense
Non-Operating Income (Expense)121125
Net Income Before Taxes524081
Income Taxes241631
Consolidated Net Income252243
Net Income From Continuing Operations272450
Net Income252243
EPS (Recurring)0.530.460.91
EPS (Basic, Before Extraordinaries)0.530.460.91
EPS (Diluted)0.520.460.90
EBITDA112135142
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio72.0653.9335.03
Price To Sales Ratio0.760.380.74
Gross Margin11.789.3013.32
Operating Margin2.892.484.37
Net Margin1.030.692.11
Shares Outstanding494948
Market Capitalization1,8361,2161,513
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$54.56$44.27$33.98$23.70$13.41 Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Sim BrandonCEO and PresidentFeb 02 '26Option Exercise23.2421,334495,8021,045,329Feb 03
Schmidt DavidDirectorJan 13 '26Option Exercise5.7920,000115,80035,763Jan 15
Lam Thomas S.DirectorDec 08 '25Option Exercise17.7829,502524,546459,122Dec 10
Sim Kenneth T.Executive ChairmanNov 10 '25Option Exercise17.7829,502524,546639,407Nov 13
Mazdyasni MatthewDirectorNov 10 '25Option Exercise18.2020,000364,00034,763Nov 12
Kitayama Mitchell WDirectorNov 07 '25Option Exercise18.2012,000218,40027,846Nov 12
Marsh LindaDirectorNov 03 '25Option Exercise18.2020,000364,000103,641Nov 05
Kitayama Mitchell WDirectorSep 15 '25Option Exercise18.208,000145,60029,060Sep 15
Schmidt DavidDirectorSep 02 '25Option Exercise18.2020,000364,00035,763Sep 03
Chiang JohnDirectorAug 13 '25Option Exercise18.2020,000364,00043,132Aug 14
Kitayama Mitchell WDirectorNov 22 '24Option Exercise18.413,40962,76021,201Nov 26
Chiang JohnDirectorNov 19 '24Option Exercise18.411,51527,89117,364Nov 20
Sim Kenneth T.Executive ChairmanNov 18 '24Option Exercise18.6528,046523,058609,905Nov 20
Marsh LindaDirectorSep 10 '24Option Exercise15.3511,000168,85080,714Sep 12
Kitayama Mitchell WDirectorSep 10 '24Option Exercise15.3511,000168,85021,314Sep 11
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.